Platinum-based Regimens

Platinum-Based Regimens is a class of cytotoxic chemotherapy protocols that employ platinum-containing compounds, such as cisplatin or carboplatin, as the primary cytotoxic agent to induce DNA damage and apoptosis in tumor cells, particularly in the context of systemic treatment for neck cancer.

4.6K

Publications

301.6K

Citations

26.9K

Authors

4.4K

Institutions

Publications per year

2017–2026

1.2K

Authors

26.9K

  1. LP
    Luis Paz‐Ares

    Hospital Universitario 12 De Octubre, Spain

    34 publications · 8K citations

    26

    h-index

  2. NC
    Nicoletta Colombo

    European Institute of Oncology, Italy

    32 publications · 8.1K citations

    24

    h-index

  3. EF
    Enriqueta Felip

    Vall d'Hebron Hospital Universitari, Spain

    41 publications · 10.5K citations

    24

    h-index

  4. MT
    Makoto Tahara

    National Cancer Center Hospital East, Japan

    40 publications · 2.6K citations

    23

    h-index

  5. EE
    Everett E. Vokes

    University of Chicago, United States

    30 publications · 4.4K citations

    23

    h-index

1–5 of 26.9K

Venues

  1. Journal of Clinical Oncology

    642 publications · 72.8K citations

    136

    h-index

  2. Cancer

    179 publications · 13K citations

    69

    h-index

  3. Annals of Oncology

    209 publications · 15.5K citations

    69

    h-index

  4. PubMed

    Repository · 411 publications · 17.3K citations

    62

    h-index

  5. British Journal of Cancer

    BJC · 148 publications · 10.9K citations

    57

    h-index

1–5